The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Implications for sentinel lymph node biopsy (SLNB) omission in patients with early-stage node-negative HR+/HER2- breast cancer undergoing mastectomy.
 
Jennifer Chen
No Relationships to Disclose
 
Kerollos Wanis
No Relationships to Disclose
 
Mahdia Rahman
No Relationships to Disclose
 
Ayushi Gianchandani
No Relationships to Disclose
 
Isabelle Bedrosian
No Relationships to Disclose
 
Nina Tamirisa
No Relationships to Disclose
 
Min Yi
No Relationships to Disclose
 
Akshara Raghavendra
No Relationships to Disclose
 
Puneet Singh
No Relationships to Disclose
 
Mediget Teshome
Research Funding - Chan Zuckerberg Initiative (Inst)
Travel, Accommodations, Expenses - Endomagnetics
 
Susie Sun
No Relationships to Disclose
 
Henry Kuerer
Consulting or Advisory Role - Merck; Targeted Medical Education, Inc.
Patents, Royalties, Other Intellectual Property - McGraw-Hill Publishing; NEJM Group
 
Kelly Hunt
Consulting or Advisory Role - Armada Health Care; AstraZeneca
Research Funding - CairnSurgical (Inst); Lilly (Inst); Lumicell (Inst)
 
Funda Meric-Bernstam
Employment - MD Anderson Cancer Center
Honoraria - Dava Oncology
Consulting or Advisory Role - AstraZeneca; Becton Dickinson; Calibr; Cybrexa Therapeutics; Daiichi Sankyo/Astra Zeneca; DAVA Pharmaceuticals; Debiopharm Group; EcoR1 Capital; eFFECTOR Therapeutics; Elevation Oncology; Exelixis; GT Aperion; Guardant Health; Harbinger Health; Incyte; Jazz Pharmaceuticals; LegoChem Biosciences; Loxo/Lilly; Menarini Group; Mersana; Molecular Templates; OnCusp Therapeutics; Protai; Ribometrix; Seagen; Tempus; Theratechnologies; Zentalis; Zymeworks
Research Funding - Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Calithera Biosciences (Inst); Curis (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); eFFECTOR Therapeutics (Inst); Genentech (Inst); Guardant Health (Inst); Jazz Pharmaceuticals (Inst); Klus Pharma (Inst); Novartis (Inst); Pfizer (Inst); PUMA Biotechnology (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Cholangiocarcinoma Foundation; Dava Oncology; ESMO; European Organisation for Research and Treatment of Cancer (EORTC)
 
Taiwo Adesoye
Consulting or Advisory Role - Boehringer labs